The forecast for spending on pharmaceutical benefits in 2025-26, which is just 8 weeks from finalisation, is $5.6 billion higher than it was four years ago, assuming most of that growth will be offset by rebates. This is not to defend the status quo but to encourage accuracy. …
Updated forecast highlights the real risk of relying on these numbers
May 13, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The 'Dispatched' Podcast Week in Review - Series 5. Ep.34
October 2, 2026 - - Podcast -
Under the TGA's new rules, the safest story is one without the patient experience
October 2, 2026 - - Latest News -
US announces formal plan that benchmarks pricing against Australia and 18 other countries
October 1, 2026 - -
Sandoz leads pharma's best workplaces as Rare Cancers Australia makes healthcare list
October 1, 2026 - - Latest News -
Eczema patients who don't respond to steroids get subsidised access to ointment
October 1, 2026 - - Latest News -
By the TGA's own test, the Health Minister's press releases are advertising
October 1, 2026 - - Latest News -
The regulator that deleted the truth from its answers now wants to police the media
October 1, 2026 - - Latest News